Eris Lifesciences Limited is a leading Indian pharmaceutical company focused on branded formulations for chronic and lifestyle-related diseases. Established in 2007, the company has rapidly expanded its presence in the domestic pharmaceutical market through a diversified portfolio covering cardiology, diabetes, nephrology, neurology, gastroenterology, dermatology, and women’s healthcare. Eris has strengthened its market position through strategic acquisitions, expanding into dermatology, injectables, and biologics while enhancing its specialty product offerings. The company emphasizes physician-focused marketing, high-quality manufacturing, and strong scientific engagement to support sustained business growth. Eris collaborates with manufacturing partners that comply with stringent regulatory standards while investing in product development and lifecycle management. Through a combination of innovation, commercial excellence, and targeted expansion into high-growth therapeutic segments, Eris Lifesciences continues to strengthen its position among India’s fastest-growing branded pharmaceutical companies.
NSE: ERIS | BSE: 540596
Ahmedabad, Gujarat, India
~2,500 employees
